Airway and systemic inflammation profile in current smokers controls, COPD current smokers and COPD ex-smokers Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Quantification of smokers and smoking status among COPD patients, hospitalized for an exacerbation Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011
Prevalence characteristics of COPD in never smokers Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012
Prevalence characteristics of COPD in never smokers Source: Annual Congress 2012 - COPD epidemiology Year: 2012
COPD hospitalizations in never smokers: comparison with current smokers Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008
Lack of effect of acute exacerbations on disease progression in ex-smoker COPD patients Source: Annual Congress 2010 - Distortions of the respiratory system in the lung function Year: 2010
Prulifloxacin in the treatment of acute exacerbations of COPD (AECOPD) in cigarette smokers Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
Sex-specific features of emphysema among current and former smokers with COPD Source: Eur Respir J 2016; 47: 104-112 Year: 2016
Does the infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation? Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009
Infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004
Budesonide/formoterol significantly improves lung function and reduces exacerbations in both smokers and ex-smokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 430s Year: 2006
The cellular composition and macrophage phenotypes in induced sputum in smokers and ex-smokers with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001
Differences in clinical and inflammatory characteristics between steroid-withdrawal-induced and spontaneous exacerbations in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 199s Year: 2002
Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021
Bronchial biopsies composition in smokers and nonsmokers in COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004
Airway inflammatory cell compounds in smokers and ex-smokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 798s Year: 2006
Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Clinical consideration and lung function in different groups of COPD patients (smokers, ex-smokers, nonsmokers) Source: International Congress 2017 – Smoking and health hazards Year: 2017